Detalhe da pesquisa
1.
A novel missense variant in ATP11C is associated with reduced red blood cell phosphatidylserine flippase activity and mild hereditary hemolytic anemia.
Am J Hematol
; 98(12): 1877-1887, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671681
2.
Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients.
Am J Hematol
; 94(5): 575-584, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30784099
3.
Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapy.
Blood
; 137(21): 2997-3001, 2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33690814
4.
Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: A phase 2, open-label study.
Am J Hematol
; 97(7): E226-E229, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384026
5.
Oxygen gradient ektacytometry-derived biomarkers are associated with vaso-occlusive crises and correlate with treatment response in sickle cell disease.
Am J Hematol
; 96(1): E29-E32, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33095451
6.
Methodological aspects of the oxygenscan in sickle cell disease: A need for standardization.
Am J Hematol
; 95(1): E5-E8, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591742
7.
Oxygen gradient ektacytometry-derived biomarkers are associated with acute complications in sickle cell disease.
Blood Adv
; 8(2): 276-286, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37976458
8.
A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell disease.
EJHaem
; 5(1): 21-32, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38406513
9.
One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study.
Blood Adv
; 7(24): 7539-7550, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37934880
10.
Effects of Genotypes and Treatment on Oxygenscan Parameters in Sickle Cell Disease.
Cells
; 10(4)2021 04 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33916502
11.
Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease.
Int J Lab Hematol
; 46(2): 390-394, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38105480
12.
Characterization of Sickling During Controlled Automated Deoxygenation with Oxygen Gradient Ektacytometry.
J Vis Exp
; (153)2019 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31762454